PRESTIGE CONSUMER HEALTHCARE (PBH) Fundamental Analysis & Valuation

NYSE:PBH • US74112D1019

Current stock price

57.325 USD
-0.2 (-0.34%)
Last:

This PBH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. PBH Profitability Analysis

1.1 Basic Checks

  • PBH had positive earnings in the past year.
  • PBH had a positive operating cash flow in the past year.
  • PBH had positive earnings in 4 of the past 5 years.
  • In the past 5 years PBH always reported a positive cash flow from operatings.
PBH Yearly Net Income VS EBIT VS OCF VS FCFPBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.34%, PBH belongs to the top of the industry, outperforming 86.39% of the companies in the same industry.
  • PBH's Return On Equity of 10.19% is amongst the best of the industry. PBH outperforms 84.82% of its industry peers.
  • PBH has a better Return On Invested Capital (7.55%) than 85.86% of its industry peers.
  • PBH had an Average Return On Invested Capital over the past 3 years of 8.16%. This is below the industry average of 13.11%.
Industry RankSector Rank
ROA 5.34%
ROE 10.19%
ROIC 7.55%
ROA(3y)3.39%
ROA(5y)4.11%
ROE(3y)6.22%
ROE(5y)8.76%
ROIC(3y)8.16%
ROIC(5y)7.67%
PBH Yearly ROA, ROE, ROICPBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

1.3 Margins

  • PBH has a Profit Margin of 16.90%. This is amongst the best in the industry. PBH outperforms 89.53% of its industry peers.
  • PBH's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 30.34%, PBH belongs to the best of the industry, outperforming 94.76% of the companies in the same industry.
  • In the last couple of years the Operating Margin of PBH has remained more or less at the same level.
  • PBH's Gross Margin of 56.12% is fine compared to the rest of the industry. PBH outperforms 67.02% of its industry peers.
  • In the last couple of years the Gross Margin of PBH has remained more or less at the same level.
Industry RankSector Rank
OM 30.34%
PM (TTM) 16.9%
GM 56.12%
OM growth 3Y0.37%
OM growth 5Y-0.32%
PM growth 3Y-0.06%
PM growth 5Y5%
GM growth 3Y-0.79%
GM growth 5Y-0.88%
PBH Yearly Profit, Operating, Gross MarginsPBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. PBH Health Analysis

2.1 Basic Checks

  • PBH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for PBH has been reduced compared to 1 year ago.
  • The number of shares outstanding for PBH has been reduced compared to 5 years ago.
  • PBH has a better debt/assets ratio than last year.
PBH Yearly Shares OutstandingPBH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
PBH Yearly Total Debt VS Total AssetsPBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • PBH has an Altman-Z score of 2.39. This is not the best score and indicates that PBH is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.39, PBH is in the better half of the industry, outperforming 61.26% of the companies in the same industry.
  • PBH has a debt to FCF ratio of 3.95. This is a good value and a sign of high solvency as PBH would need 3.95 years to pay back of all of its debts.
  • PBH has a better Debt to FCF ratio (3.95) than 86.91% of its industry peers.
  • A Debt/Equity ratio of 0.58 indicates that PBH is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.58, PBH is doing worse than 68.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 3.95
Altman-Z 2.39
ROIC/WACC0.85
WACC8.86%
PBH Yearly LT Debt VS Equity VS FCFPBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • PBH has a Current Ratio of 3.11. This indicates that PBH is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of PBH (3.11) is comparable to the rest of the industry.
  • PBH has a Quick Ratio of 1.93. This is a normal value and indicates that PBH is financially healthy and should not expect problems in meeting its short term obligations.
  • PBH has a Quick ratio (1.93) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 3.11
Quick Ratio 1.93
PBH Yearly Current Assets VS Current LiabilitesPBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. PBH Growth Analysis

3.1 Past

  • PBH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.92%.
  • Measured over the past years, PBH shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.88% on average per year.
  • PBH shows a decrease in Revenue. In the last year, the revenue decreased by -1.31%.
  • PBH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.39% yearly.
EPS 1Y (TTM)6.92%
EPS 3Y3.72%
EPS 5Y8.88%
EPS Q2Q%-6.56%
Revenue 1Y (TTM)-1.31%
Revenue growth 3Y1.54%
Revenue growth 5Y3.39%
Sales Q2Q%-2.37%

3.2 Future

  • Based on estimates for the next years, PBH will show a small growth in Earnings Per Share. The EPS will grow by 4.28% on average per year.
  • The Revenue is expected to grow by 0.71% on average over the next years.
EPS Next Y1.22%
EPS Next 2Y3.53%
EPS Next 3Y4.4%
EPS Next 5Y4.28%
Revenue Next Year-2.54%
Revenue Next 2Y0.83%
Revenue Next 3Y2.81%
Revenue Next 5Y0.71%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PBH Yearly Revenue VS EstimatesPBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
PBH Yearly EPS VS EstimatesPBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

7

4. PBH Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.80 indicates a correct valuation of PBH.
  • Based on the Price/Earnings ratio, PBH is valued cheaper than 87.96% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.66, PBH is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 11.81, the valuation of PBH can be described as very reasonable.
  • 85.34% of the companies in the same industry are more expensive than PBH, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of PBH to the average of the S&P500 Index (38.00), we can say PBH is valued rather cheaply.
Industry RankSector Rank
PE 12.8
Fwd PE 11.81
PBH Price Earnings VS Forward Price EarningsPBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • PBH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PBH is cheaper than 88.48% of the companies in the same industry.
  • PBH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PBH is cheaper than 91.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.15
EV/EBITDA 10.18
PBH Per share dataPBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PBH does not grow enough to justify the current Price/Earnings ratio.
  • PBH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)10.46
PEG (5Y)1.44
EPS Next 2Y3.53%
EPS Next 3Y4.4%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PBH Dividend Analysis

5.1 Amount

  • PBH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PBH Fundamentals: All Metrics, Ratios and Statistics

PRESTIGE CONSUMER HEALTHCARE

NYSE:PBH (4/22/2026, 10:29:39 AM)

57.325

-0.2 (-0.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05
Earnings (Next)04-30
Inst Owners110.74%
Inst Owner Change0.09%
Ins Owners1.33%
Ins Owner Change-0.49%
Market Cap2.71B
Revenue(TTM)1.10B
Net Income(TTM)186.50M
Analysts84
Price Target79.76 (39.14%)
Short Float %5.77%
Short Ratio5.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.91%
Min EPS beat(2)-1.36%
Max EPS beat(2)9.18%
EPS beat(4)2
Avg EPS beat(4)0.63%
Min EPS beat(4)-5.96%
Max EPS beat(4)9.18%
EPS beat(8)4
Avg EPS beat(8)-0.63%
EPS beat(12)6
Avg EPS beat(12)-46.73%
EPS beat(16)10
Avg EPS beat(16)-34.55%
Revenue beat(2)1
Avg Revenue beat(2)2.53%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)5.55%
Revenue beat(4)2
Avg Revenue beat(4)0.29%
Min Revenue beat(4)-5.34%
Max Revenue beat(4)5.55%
Revenue beat(8)4
Avg Revenue beat(8)-0.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)8
Avg Revenue beat(16)0.2%
PT rev (1m)1.03%
PT rev (3m)0.9%
EPS NQ rev (1m)-0.17%
EPS NQ rev (3m)-1.22%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)-0.41%
Revenue NQ rev (1m)-0.61%
Revenue NQ rev (3m)-2.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.54%
Valuation
Industry RankSector Rank
PE 12.8
Fwd PE 11.81
P/S 2.46
P/FCF 10.15
P/OCF 9.81
P/B 1.48
P/tB N/A
EV/EBITDA 10.18
EPS(TTM)4.48
EY7.82%
EPS(NY)4.86
Fwd EY8.47%
FCF(TTM)5.65
FCFY9.85%
OCF(TTM)5.85
OCFY10.2%
SpS23.32
BVpS38.66
TBVpS-22.26
PEG (NY)10.46
PEG (5Y)1.44
Graham Number62.4264 (8.9%)
Profitability
Industry RankSector Rank
ROA 5.34%
ROE 10.19%
ROCE 9.98%
ROIC 7.55%
ROICexc 7.69%
ROICexgc 61.8%
OM 30.34%
PM (TTM) 16.9%
GM 56.12%
FCFM 24.21%
ROA(3y)3.39%
ROA(5y)4.11%
ROE(3y)6.22%
ROE(5y)8.76%
ROIC(3y)8.16%
ROIC(5y)7.67%
ROICexc(3y)8.33%
ROICexc(5y)7.8%
ROICexgc(3y)85.26%
ROICexgc(5y)93.76%
ROCE(3y)10.78%
ROCE(5y)10.14%
ROICexgc growth 3Y-14.1%
ROICexgc growth 5Y-7.82%
ROICexc growth 3Y5.03%
ROICexc growth 5Y3.52%
OM growth 3Y0.37%
OM growth 5Y-0.32%
PM growth 3Y-0.06%
PM growth 5Y5%
GM growth 3Y-0.79%
GM growth 5Y-0.88%
F-Score5
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 3.95
Debt/EBITDA 2.88
Cap/Depr 31.31%
Cap/Sales 0.86%
Interest Coverage 7.66
Cash Conversion 75.79%
Profit Quality 143.26%
Current Ratio 3.11
Quick Ratio 1.93
Altman-Z 2.39
F-Score5
WACC8.86%
ROIC/WACC0.85
Cap/Depr(3y)27.42%
Cap/Depr(5y)37.16%
Cap/Sales(3y)0.75%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.92%
EPS 3Y3.72%
EPS 5Y8.88%
EPS Q2Q%-6.56%
EPS Next Y1.22%
EPS Next 2Y3.53%
EPS Next 3Y4.4%
EPS Next 5Y4.28%
Revenue 1Y (TTM)-1.31%
Revenue growth 3Y1.54%
Revenue growth 5Y3.39%
Sales Q2Q%-2.37%
Revenue Next Year-2.54%
Revenue Next 2Y0.83%
Revenue Next 3Y2.81%
Revenue Next 5Y0.71%
EBIT growth 1Y1.3%
EBIT growth 3Y1.92%
EBIT growth 5Y3.06%
EBIT Next Year5.19%
EBIT Next 3Y5.45%
EBIT Next 5Y2.82%
FCF growth 1Y15.15%
FCF growth 3Y-0.94%
FCF growth 5Y4.02%
OCF growth 1Y14.78%
OCF growth 3Y-1.09%
OCF growth 5Y2.99%

PRESTIGE CONSUMER HEALTHCARE / PBH Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PRESTIGE CONSUMER HEALTHCARE (PBH) stock?

ChartMill assigns a fundamental rating of 5 / 10 to PBH.


Can you provide the valuation status for PRESTIGE CONSUMER HEALTHCARE?

ChartMill assigns a valuation rating of 7 / 10 to PRESTIGE CONSUMER HEALTHCARE (PBH). This can be considered as Undervalued.


Can you provide the profitability details for PRESTIGE CONSUMER HEALTHCARE?

PRESTIGE CONSUMER HEALTHCARE (PBH) has a profitability rating of 7 / 10.


What is the valuation of PRESTIGE CONSUMER HEALTHCARE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for PRESTIGE CONSUMER HEALTHCARE (PBH) is 12.8 and the Price/Book (PB) ratio is 1.48.


What is the financial health of PRESTIGE CONSUMER HEALTHCARE (PBH) stock?

The financial health rating of PRESTIGE CONSUMER HEALTHCARE (PBH) is 6 / 10.